From the cancer mechanisms point of view, on the one hand, the fact that STAT5A is not down-regulated in KIRC may allow this tumor to regulate its behaviour not through up- or down-regulation of the gene itself, but through the dysregulation of the specific genes in each of the paths, tuning gene activity through the path and not the gene. This evidence concerns the gene STAT5A and neoplasm.